or
forgot password
  • cancer clinical trials in palo alto, CA

  • Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
    Palo Alto Medical Foundation
    Palo Alto, California 94301
    Breast Cancer, Psychosocial Effects of Cancer and Its Treatment
    Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
    Palo Alto Medical Foundation
    Palo Alto, California 94301
    Breast Cancer
    Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
    Stanford CRS
    Palo Alto, California 94305
    HIV Infections, Sexually Transmitted Diseases
    Cisplatin Plus Epinephrine in Treating Patients With Recurrent or Refractory Head and Neck Cancer
    Veterans Affairs Medical Center - Palo Alto
    Palo Alto, California 94304
    Head and Neck Cancer
    Combination Chemotherapy in Treating Children With Stage III or Stage IV Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia
    Lucile Packard Children's Hospital at Stanford
    Palo Alto, California 94304
    Leukemia, Lymphoma
    Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer
    Women's Cancer Center
    Palo Alto, California 94304
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic Leukemia
    Lucile Packard Children's Hospital at Stanford
    Palo Alto, California 94304
    Leukemia
    Antibiotic Therapy With or Without G-CSF in Treating Children With Neutropenia and Fever Caused by Chemotherapy
    Lucile Packard Children's Hospital at Stanford
    Palo Alto, California 94304
    Fever, Sweats, and Hot Flashes, Neutropenia, Unspecified Childhood Solid Tumor, Protocol Specific
    Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia
    Lucile Packard Children's Hospital at Stanford
    Palo Alto, California 94304
    Leukemia
    Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors
    Lucile Packard Children's Hospital at Stanford
    Palo Alto, California 94304
    Childhood Germ Cell Tumor, Drug/Agent Toxicity by Tissue/Organ, Extragonadal Germ Cell Tumor, Ovarian Cancer
    Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma
    Lucile Packard Children's Hospital at Stanford
    Palo Alto, California 94304
    Brain and Central Nervous System Tumors
    Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma
    Lucile Packard Children's Hospital at Stanford University Medical Center
    Palo Alto, California 95798
    Sarcoma
    STI571 in Treating Patients With Recurrent Leukemia
    Lucile Packard Children's Hospital at Stanford
    Palo Alto, California 94304
    Leukemia
    Tipifarnib in Treating Patients With Myeloproliferative Disorders
    Veterans Affairs Medical Center - Palo Alto
    Palo Alto, California 94304
    Leukemia, Myelodysplastic/Myeloproliferative Neoplasms
    Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma
    Lucile Packard Children's Hospital at Stanford
    Palo Alto, California 94304
    Brain and Central Nervous System Tumors
    Paclitaxel in Treating Patients With Ovarian Stromal Cancer
    Palo Alto Medical Foundation
    Palo Alto, California 94301
    Ovarian Cancer
    Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
    Lucile Packard Children's Hospital at Stanford
    Palo Alto, California 94304
    Leukemia
    Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
    Veterans Affairs Medical Center - Palo Alto
    Palo Alto, California 94304
    Lung Cancer
    Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
    Lucile Packard Children's Hospital at Stanford University Medical Center
    Palo Alto, California 95798
    Sarcoma
    Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neuroblastoma
    Lucile Packard Children's Hospital Stanford University
    Palo Alto, California 94304
    Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4S Neuroblastoma
    Low-Dose Radiation Therapy and Combination Chemotherapy Following Surgery in Treating Children With Newly Diagnosed Primitive Neuroectodermal Tumor or Medulloblastoma
    Lucile Packard Children's Hospital at Stanford University Medical Center
    Palo Alto, California 95798
    Brain and Central Nervous System Tumors
    Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma
    Lucile Packard Children's Hospital Stanford University
    Palo Alto, California 94304
    Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4S Neuroblastoma
    Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    Veterans Affairs Medical Center - Palo Alto
    Palo Alto, California 94304
    Multiple Myeloma and Plasma Cell Neoplasm
    Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
    Lucile Packard Children's Hospital Stanford University
    Palo Alto, California 94304
    Childhood Embryonal Tumor, Childhood Extracranial Germ Cell Tumor, Childhood Extragonadal Germ Cell Tumor, Childhood Malignant Ovarian Germ Cell Tumor, Childhood Malignant Testicular Germ Cell Tumor, Childhood Teratoma, Ovarian Embryonal Carcinoma, Ovarian Yolk Sac Tumor, Stage II Malignant Testicular Germ Cell Tumor, Stage IIA Ovarian Germ Cell Tumor, Stage IIB Ovarian Germ Cell Tumor, Stage IIC Ovarian Germ Cell Tumor, Stage III Malignant Testicular Germ Cell Tumor, Stage IIIA Ovarian Germ Cell Tumor, Stage IIIB Ovarian Germ Cell Tumor, Stage IIIC Ovarian Germ Cell Tumor, Testicular Choriocarcinoma and Yolk Sac Tumor, Testicular Embryonal Carcinoma
    Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma
    Veterans Affairs Medical Center - Palo Alto
    Palo Alto, California 94304
    Melanoma (Skin)
    Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    Veterans Affairs Medical Center - Palo Alto
    Palo Alto, California 94304
    Lymphoma
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Palo Alto Medical Foundation Heath Care
    Palo Alto, California 94301
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Study of Late-Occurring Complications in Childhood Cancer Survivors
    Lucile Packard Children's Hospital Stanford University
    Palo Alto, California 94304
    Cancer Survivor, Cardiovascular Complications, Hematopoietic/Lymphoid Cancer, Unspecified Childhood Solid Tumor, Protocol Specific
    N2001-03: CEP-701 in Treating Young Patients With Recurrent or Refractory High-Risk Neuroblastoma
    Lucille Salter Packer Children's Hospital, Stanford University
    Palo Alto, California 94305
    Neuroblastoma
    Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma
    Lucile Packard Children's Hospital at Stanford University Medical Center
    Palo Alto, California 95798
    Brain Tumor, Central Nervous System Tumor
    DNA Variations in the Gene in Young Patients With Wilms' Tumor
    Lucile Packard Children's Hospital at Stanford University Medical Center
    Palo Alto, California 95798
    Kidney Cancer
    Long-Term Effects of Treatment in Patients Previously Treated for Childhood Hodgkin's Lymphoma
    Lucile Packard Children's Hospital at Stanford University Medical Center
    Palo Alto, California 95798
    Long-term Effects Secondary to Cancer Therapy in Children, Lymphoma
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes
    Lucile Packard Children's Hospital at Stanford University Medical Center
    Palo Alto, California 95798
    Leukemia
    Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
    Lucile Packard Children's Hospital Stanford University
    Palo Alto, California 94304
    Localized Osteosarcoma, Metastatic Osteosarcoma
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    VA Palo Alto Health Care System

    Trial Locations
    VA Palo Alto Health Care System
    Palo Alto Medical Foundation Heath Care
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission
    Lucile Packard Children's Hospital at Stanford University Medical Center
    Palo Alto, California 95798
    Leukemia
    Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma
    Lucile Packard Children's Hospital at Stanford University Medical Center
    Palo Alto, California 95798
    Neuroblastoma
    Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor
    Lucile Packard Children's Hospital Stanford University
    Palo Alto, California 94304
    Stage I Adrenocortical Carcinoma, Stage II Adrenocortical Carcinoma, Stage III Adrenocortical Carcinoma, Stage IV Adrenocortical Carcinoma
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Palo Alto Medical Foundation Heath Care
    Palo Alto, California 94301
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    VA Palo Alto Health Care System

    Trial Locations
    VA Palo Alto Health Care System
    Palo Alto Medical Foundation Heath Care
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
    Lucile Packard Children's Hospital Stanford University
    Palo Alto, California 94304
    Stage I Wilms Tumor, Stage II Wilms Tumor, Stage III Wilms Tumor
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
    Lucile Packard Children's Hospital Stanford University
    Palo Alto, California 94304
    Adult Malignant Mesenchymoma, Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Childhood Malignant Mesenchymoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
    Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
    Lucile Packard Children's Hospital at Stanford University Medical Center
    Palo Alto, California 95798
    Leukemia, Myelodysplastic Syndromes
    Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
    Lucile Packard Children's Hospital Stanford University
    Palo Alto, California 94304
    Stage III Wilms Tumor, Stage IV Wilms Tumor
    Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor
    Lucile Packard Children's Hospital Stanford University
    Palo Alto, California 94304
    Untreated Childhood Medulloblastoma, Untreated Childhood Pineoblastoma, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
    Lucile Packard Children's Hospital Stanford University
    Palo Alto, California 94304
    Contiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, T-cell Adult Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Palo Alto Medical Foundation Heath Care
    Palo Alto, California 94301
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
    Lucile Packard Children's Hospital at Stanford University Medical Center
    Palo Alto, California 95798
    Cognitive/Functional Effects, Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment
    Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
    Lucile Packard Children's Hospital at Stanford University Medical Center
    Palo Alto, California 95798
    Ototoxicity, Unspecified Childhood Solid Tumor, Protocol Specific
    Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors
    Lucile Packard Children's Hospital at Stanford University Medical Center
    Palo Alto, California 95798
    Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Ovarian Cancer, Testicular Germ Cell Tumor
    Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Palo Alto Medical Foundation
    Palo Alto, California 94301
    Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma
    Lucile Packard Children's Hospital at Stanford University Medical Center
    Palo Alto, California 95798
    Neuroblastoma
    N2004-06: Irinotecan and Vincristine With 131I-MIBG Therapy for Resistant/Relapsed High-Risk Neuroblastoma
    Lucile Packard Children's Hospital at Stanford University Medical Center
    Palo Alto, California 95798
    Neuroblastoma
    Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma
    Lucile Packard Children's Hospital Stanford University
    Palo Alto, California 94304
    Extraocular Retinoblastoma
    Combination Chemotherapy With or Without Lestaurtinib in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
    Lucile Packard Children's Hospital at Stanford University Medical Center
    Palo Alto, California 95798
    Leukemia
    Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
    Lucile Packard Children's Hospital at Stanford University Medical Center
    Palo Alto, California 95798
    Neuroblastoma